跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Imatrop - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Imatrop
Approved
STANDARD
Imatrop
Gufic Biosciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f68efee508a5cfac
Company
Gufic Biosciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
f68efee508a5cfac
Drug Approval Philippines Name
Imatrop
Product Name
Imatrop
Registration Number
DR-XY43786
Brand Name
Imatrop
Generic Name
Sodium Nitroprusside
Dosage Form
Lyophilized Powder for Injection (IV)
Dosage Strength
50 mg
Manufacturer
Gufic Biosciences Pvt. Ltd.
Trader
Immaculate Lifesciences (P) Ltd
Importer
SRS Life Sciences Inc.
Distributor
SRS Life Sciences Inc.
Issuance Date
25 August 2024
Expiry Date
16 October 2029
Pharmacologic Category
Antihypertensive (Nitroferricyanide derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f68efee508a5cfac
Type
Standard
Back to Philippines FDA Approvals